Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...

Patients with rosacea and skin of color are more likely to have severe disease phenotypes when compared with White patients with rosacea.

Your skin holds vital clues about your health. From thyroid issues to heart problems, discover what your skin is trying to ...

In the Minocycline Versus Oracea® in Rosacea-1 (MVOR-1 ... Secondary endpoints included the reduction in Clinician’s Erythema Assessment (CEA) score. Results from MVOR-1 showed 65.0% IGA ...

Journey Medical plans to highlight the launch of Emrosi™ and showcase its line of prescription dermatology products. The FDA approved Emrosi for the treatment of inflammatory lesions of rosacea in ...

Your skin can signal hidden health issues, from diabetes to liver disease. Learn how to recognize early warning signs before conditions worsen.

Rosacea affects approximately 5% of the U.S ... Additionally, Emrosi's approval excludes erythema (redness), a key differentiator. However, with strong execution, established market presence ...

Rosacea: diagnosis and treatment. Logger JGM, Olydam JI, Driessen RJB. Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of ...